- Home
- DNTH vs AAOI Comparison
DNTH vs AAOI Comparison
Compare DNTH & AAOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- AAOI
- Stock Information
- Founded
- DNTH 2015
- AAOI 1997
- Country
- DNTH United States
- AAOI United States
- Employees
- DNTH N/A
- AAOI N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- AAOI Semiconductors
- Sector
- DNTH Health Care
- AAOI Technology
- Exchange
- DNTH Nasdaq
- AAOI Nasdaq
- Market Cap
- DNTH 1.5B
- AAOI 1.6B
- IPO Year
- DNTH N/A
- AAOI 2013
- Fundamental
- Price
- DNTH $36.05
- AAOI $31.17
- Analyst Decision
- DNTH Strong Buy
- AAOI Buy
- Analyst Count
- DNTH 11
- AAOI 6
- Target Price
- DNTH $65.22
- AAOI $28.40
- AVG Volume (30 Days)
- DNTH 664.6K
- AAOI 5.0M
- Earning Date
- DNTH 11-06-2025
- AAOI 11-06-2025
- Dividend Yield
- DNTH N/A
- AAOI N/A
- EPS Growth
- DNTH N/A
- AAOI N/A
- EPS
- DNTH N/A
- AAOI N/A
- Revenue
- DNTH $4,854,000.00
- AAOI $368,233,000.00
- Revenue This Year
- DNTH N/A
- AAOI $96.63
- Revenue Next Year
- DNTH N/A
- AAOI $62.31
- P/E Ratio
- DNTH N/A
- AAOI N/A
- Revenue Growth
- DNTH 17.87
- AAOI 77.94
- 52 Week Low
- DNTH $13.37
- AAOI $9.71
- 52 Week High
- DNTH $40.16
- AAOI $44.50
- Technical
- Relative Strength Index (RSI)
- DNTH 57.06
- AAOI 55.95
- Support Level
- DNTH $33.34
- AAOI $26.66
- Resistance Level
- DNTH $36.68
- AAOI $35.20
- Average True Range (ATR)
- DNTH 2.11
- AAOI 3.25
- MACD
- DNTH -0.53
- AAOI 0.01
- Stochastic Oscillator
- DNTH 39.74
- AAOI 61.29
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About AAOI Applied Optoelectronics Inc.
Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.